These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 19487459)
1. Differential regulation of cyclin-dependent kinase 4 (CDK4) and CDK6, evidence that CDK4 might not be activated by CDK7, and design of a CDK6 activating mutation. Bockstaele L; Bisteau X; Paternot S; Roger PP Mol Cell Biol; 2009 Aug; 29(15):4188-200. PubMed ID: 19487459 [TBL] [Abstract][Full Text] [Related]
2. CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point. Bisteau X; Paternot S; Colleoni B; Ecker K; Coulonval K; De Groote P; Declercq W; Hengst L; Roger PP PLoS Genet; 2013 May; 9(5):e1003546. PubMed ID: 23737759 [TBL] [Abstract][Full Text] [Related]
3. Rb inactivation in cell cycle and cancer: the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase. Paternot S; Bockstaele L; Bisteau X; Kooken H; Coulonval K; Roger PP Cell Cycle; 2010 Feb; 9(4):689-99. PubMed ID: 20107323 [TBL] [Abstract][Full Text] [Related]
7. p27Kip1 inhibits cyclin D-cyclin-dependent kinase 4 by two independent modes. Ray A; James MK; Larochelle S; Fisher RP; Blain SW Mol Cell Biol; 2009 Feb; 29(4):986-99. PubMed ID: 19075005 [TBL] [Abstract][Full Text] [Related]
8. Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors". Bockstaele L; Kooken H; Libert F; Paternot S; Dumont JE; de Launoit Y; Roger PP; Coulonval K Mol Cell Biol; 2006 Jul; 26(13):5070-85. PubMed ID: 16782892 [TBL] [Abstract][Full Text] [Related]
9. Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop. Garrett S; Barton WA; Knights R; Jin P; Morgan DO; Fisher RP Mol Cell Biol; 2001 Jan; 21(1):88-99. PubMed ID: 11113184 [TBL] [Abstract][Full Text] [Related]
10. Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis. Masaki T; Shiratori Y; Rengifo W; Igarashi K; Yamagata M; Kurokohchi K; Uchida N; Miyauchi Y; Yoshiji H; Watanabe S; Omata M; Kuriyama S Hepatology; 2003 Mar; 37(3):534-43. PubMed ID: 12601350 [TBL] [Abstract][Full Text] [Related]
11. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes. Sarcevic B; Lilischkis R; Sutherland RL J Biol Chem; 1997 Dec; 272(52):33327-37. PubMed ID: 9407125 [TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinase-2 (Cdk2) forms an inactive complex with cyclin D1 since Cdk2 associated with cyclin D1 is not phosphorylated by Cdk7-cyclin-H. Higashi H; Suzuki-Takahashi I; Saitoh S; Segawa K; Taya Y; Okuyama A; Nishimura S; Kitagawa M Eur J Biochem; 1996 Apr; 237(2):460-7. PubMed ID: 8647086 [TBL] [Abstract][Full Text] [Related]
13. Regulation of CDK7-carboxyl-terminal domain kinase activity by the tumor suppressor p16(INK4A) contributes to cell cycle regulation. Nishiwaki E; Turner SL; Harju S; Miyazaki S; Kashiwagi M; Koh J; Serizawa H Mol Cell Biol; 2000 Oct; 20(20):7726-34. PubMed ID: 11003668 [TBL] [Abstract][Full Text] [Related]
14. The cyclin D3-CDK4-p27kip1 holoenzyme in thyroid epithelial cells: activation by TSH, inhibition by TGFbeta, and phosphorylations of its subunits demonstrated by two-dimensional gel electrophoresis. Coulonval K; Bockstaele L; Paternot S; Dumont JE; Roger PP Exp Cell Res; 2003 Nov; 291(1):135-49. PubMed ID: 14597415 [TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP inhibits the proliferation of thyroid carcinoma cell lines through regulation of CDK4 phosphorylation. Rocha AS; Paternot S; Coulonval K; Dumont JE; Soares P; Roger PP Mol Biol Cell; 2008 Nov; 19(11):4814-25. PubMed ID: 18799615 [TBL] [Abstract][Full Text] [Related]